CSF2 and hepatocellular carcinoma: Other cytokine combinations, such as IL-5 and GM-CSF, were found to be new potential therapeutic tools, and highlighted the ability of the subset of cytokine-releasing cells of the peritoneal cavity to counteract cirrhosis progression leading to HCC development.